GlassScriptPhysician profile
Susanne Mathew
NPI 1386208403
$1,534.05
in general payments reported to CMS, 2019-2025
20 companies · $753 in 2025
The $753 reported for 2025 was more than what 88% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $206 · 2024: $575 · 2025: $753.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,534.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,534.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shield Therapeutics INC | $301.73 | 2023-2025 | |
| Astellas Pharma US INC | $225.34 | 2024-2025 | Veozah |
| Biogen, INC. | $155.06 | 2025 | Zurzuvae |
| Coopersurgical, INC. | $113.78 | 2025 | Paragard T 380a |
| Dexcom, INC. | $110.39 | 2023 | Dexcom G7 Gss (161) |
| Exact Sciences Corporation | $96.49 | 2023-2025 | Cologuard Collection Kit |
| Sumitomo Pharma America, INC. | $93.07 | 2024-2025 | Myfembree, Gemtesa |
| Daiichi Sankyo INC. | $80.72 | 2025 | Injectafer |
| Organon LLC | $67.37 | 2023-2025 | Nexplanon |
| Hologic Sales and Service, LLC | $48.92 | 2025 | Fetal Fibronectin Enzyme Immunoassay |
| Merck Sharp & Dohme LLC | $36.39 | 2024-2025 | Gardasil 9, Gardasil |
| Exeltis, USA INC. | $33.86 | 2025 | Slynd |
| Ethicon US, LLC | $31.73 | 2025 | Ethicon |
| Millicent US INC | $28.76 | 2024-2025 | Intrarosa, Femlyv |
| Abbott Laboratories | $23.92 | 2024 | Jot Dx |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $21.63 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $19.86 | 2025 | |
| Novo Nordisk INC | $17.44 | 2025 | Wegovy |
| Becton, Dickinson and Company | $16.12 | 2024 | Arista Ah Flexitip |
| Channel Medsystems, INC. | $11.47 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susanne Mathew listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.